
TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - Workshops
JO  - International Journal of Andrology
VL  - 28
IS  - s1
SN  - 0105-6263
UR  - https://doi.org/10.1111/j.1365-2605.2005.00551_2.x
DO  - doi:10.1111/j.1365-2605.2005.00551_2.x
SP  - 4
EP  - 9
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - International Journal of Andrology
VL  - 28
IS  - s1
SN  - 0105-6263
UR  - https://doi.org/10.1111/j.1365-2605.2005.00551_5.x
DO  - doi:10.1111/j.1365-2605.2005.00551_5.x
SP  - 45
EP  - 129
PY  - 2005
ER  - 

TY  - JOUR
TI  - Seoul Satellite Symposium
JO  - International Journal of Andrology
VL  - 28
IS  - s1
SN  - 0105-6263
UR  - https://doi.org/10.1111/j.1365-2605.2005.00551_7.x
DO  - doi:10.1111/j.1365-2605.2005.00551_7.x
SP  - 132
EP  - 133
PY  - 2005
ER  - 

TY  - JOUR
AU  - Mistry, Akshitkumar M.
AU  - Greenplate, Allison R.
AU  - Ihrie, Rebecca A.
AU  - Irish, Jonathan M.
TI  - Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors
JO  - The FEBS Journal
JA  - FEBS J
VL  - 286
IS  - 8
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.14730
DO  - doi:10.1111/febs.14730
SP  - 1523
EP  - 1539
KW  - immune cell
KW  - immunotherapy
KW  - mass cytometry
KW  - proteomics
KW  - signaling
KW  - single cell
PY  - 2019
AB  - Single-cell technologies that can quantify features of individual cells within a tumor are critical for treatment strategies aiming to target cancer cells while sparing or activating beneficial cells. Given that key players in protein networks are often the primary targets of precision oncology strategies, it is imperative to transcend the nucleic acid message and read cellular actions in human solid tumors. Here, we review the advantages of multiplex, single-cell mass cytometry in tissue and solid tumor investigations. Mass cytometry can quantitatively probe nearly any cellular feature or target. In discussing the ability of mass cytometry to reveal and characterize a broad spectrum of cell types, identify rare cells, and study functional behavior through protein signaling networks in millions of individual cells from a tumor, this review surveys publications of scientific advances in solid tumor biology made with the aid of mass cytometry. Advances discussed include functional identification of rare tumor and tumor-infiltrating immune cells and dissection of cellular mechanisms of immunotherapy in solid tumors and the periphery. The review concludes by highlighting ways to incorporate single-cell mass cytometry in solid tumor precision oncology efforts and rapidly developing cytometry techniques for quantifying cell location and sequenced nucleic acids.
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - APMIS
VL  - 120
IS  - s134
SN  - 0903-4641
UR  - https://doi.org/10.1111/j.1600-0463.2012.02894.x
DO  - doi:10.1111/j.1600-0463.2012.02894.x
SP  - 18
EP  - 39
PY  - 2012
ER  - 

TY  - JOUR
TI  - 39th Annual Meeting of the International Continence Society San Francisco, USA 29 September – 3 October, 2009
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodyn.
VL  - 28
IS  - 7
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.20808
DO  - doi:10.1002/nau.20808
SP  - 567
EP  - 935
PY  - 2009
ER  - 

TY  - JOUR
TI  - THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION
JO  - Australian and New Zealand Journal of Medicine
VL  - 30
IS  - 4
SN  - 0004-8291
UR  - https://doi.org/10.1111/j.1445-5994.2000.tb02071.x
DO  - doi:10.1111/j.1445-5994.2000.tb02071.x
SP  - 523
EP  - 549
PY  - 2000
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 8
IS  - s2
SN  - 1365-182X
UR  - https://doi.org/10.1080/16515320600855338
DO  - doi:10.1080/16515320600855338
SP  - 3
EP  - 256
PY  - 2006
ER  - 

TY  - JOUR
C7  - e12524
TI  - Abstracts
JO  - Microcirculation
JA  - Microcirculation
VL  - 26
IS  - 4
SN  - 1073-9688
UR  - https://doi.org/10.1111/micc.12524
DO  - doi:10.1111/micc.12524
SP  - e12524
PY  - 2019
ER  - 

TY  - JOUR
AU  - Boskabady, Mohammad Hossein
AU  - Farkhondeh, Tahereh
C8  - PTR-16-0008.R1
TI  - Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents
JO  - Phytotherapy Research
JA  - Phytother. Res.
VL  - 30
IS  - 7
SN  - 0951-418X
UR  - https://doi.org/10.1002/ptr.5622
DO  - doi:10.1002/ptr.5622
SP  - 1072
EP  - 1094
KW  - Crocus sativus
KW  - crocins
KW  - crocetin
KW  - safranal
KW  - antiinflammatory
KW  - antioxidant
KW  - immunomodulation
PY  - 2016
AB  - Crocus sativus L. (C.?sativus), commonly known as saffron, is used as a food additive, preservative, and medicinal herb. Traditionally, it has been used as an alternative treatment for different diseases. C.?sativus' medicinal effects are related to its major constituents like crocins, crocetin, and safranal. According to the literature, C.?sativus and its constituents could be considered as an effective treatment for neurodegenerative disorders, coronary artery diseases, asthma, bronchitis, colds, fever, diabetes, and so on. Recently, numerous studies have reported such medicinal properties and found that the underlying mechanisms of action may be mediated by antioxidant, inflammatory, and immunomodulatory effects. C.?sativus enhances the antioxidant capacity and acts as a free radical scavenger. As an antiinflammatory and immunomodulatory agent, it modulates inflammatory mediators, humoral immunity, and cell-mediated immunity responses. This review highlights in vitro and animal findings regarding antiinflammatory, antioxidant, and immunomodulatory effects of C.?sativus and its constituents. Present review found that the C.?sativus and its main constituents such as safranal, crocins, and crocetin could be effective against various diseases because of their antioxidant, anti-inflammation, and immunomodulatory effects. Copyright ? 2016 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Plenary Paper Session
JO  - Journal of the American Geriatrics Society
VL  - 59
IS  - s1
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2011.03416.x
DO  - doi:10.1111/j.1532-5415.2011.03416.x
SP  - S1
EP  - S232
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 25
IS  - S4
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.13200
DO  - doi:10.1111/exd.13200
SP  - 3
EP  - 51
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Respirology
VL  - 13
IS  - s5
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2008.01430.x
DO  - doi:10.1111/j.1440-1843.2008.01430.x
SP  - A139
EP  - A208
PY  - 2008
ER  - 

TY  - JOUR
AU  - Hugh, Thomas J.
AU  - Poston, Graeme J.
TI  - THE AETIOLOGY AND MANAGEMENT OF HEPATIC METASTASES
JO  - Australian and New Zealand Journal of Surgery
VL  - 67
IS  - 7
SN  - 0004-8682
UR  - https://doi.org/10.1111/j.1445-2197.1997.tb02003.x
DO  - doi:10.1111/j.1445-2197.1997.tb02003.x
SP  - 400
EP  - 409
KW  - hepatic metastases
KW  - hepatic resection.
PY  - 1997
AB  - Hepatic metastases are a common event in the metastatic spread of primary tumours and indicate advanced disease. However, the presence of hepatic metastases does not necessarily imply incurability; in selected patients resection of hepatic metastases may result in 5-year survival rates of 25?35%, usually in patients with colorectal liver metastases in whom solitary metastases are more frequent than with other primary tumours. However, hepatic metastases from Wilm's tumours, adrenal tumours, renal cell carcinoma, and neuroendocrine tumours may also be resected with similar success rates. A poor prognosis after resection of hepatic metastases is likely when there are more than three metastatic deposits, involved resection margins (often as a result of ?wedge? resections), when there is extrahepatic disease, or nodal involvement at the primary tumour site. Cyto-reductive procedures may provide excellent palliation and possibly long-term survival in selected patients with hepatic metastases unsuitable for resection. However, further study is required to establish the appropriate role for these treatments.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - American Journal of Transplantation
JA  - American Journal of Transplantation
VL  - 13
IS  - S5
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12266
DO  - doi:10.1111/ajt.12266
SP  - 207
EP  - 554
PY  - 2013
AB  - First page of article
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 282
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.13339
DO  - doi:10.1111/febs.13339
SP  - 55
EP  - 422
PY  - 2015
ER  - 

TY  - JOUR
TI  - ABSTRACTS—SYMPOSIA
JO  - Alcoholism: Clinical and Experimental Research
VL  - 31
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2007.00413.x
DO  - doi:10.1111/j.1530-0277.2007.00413.x
SP  - 249A
EP  - 316A
PY  - 2007
ER  - 

TY  - JOUR
TI  - 2014 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 66
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.38914
DO  - doi:10.1002/art.38914
SP  - S1
EP  - S1402
PY  - 2014
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Tissue Engineering and Regenerative Medicine
JA  - J Tissue Eng Regen Med
VL  - 8
IS  - s1
SN  - 1932-6254
UR  - https://doi.org/10.1002/term.1932
DO  - doi:10.1002/term.1932
SP  - 207
EP  - 518
PY  - 2014
ER  - 
